Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Wanjia Group Holdings Limited operates as an investment holding company, primarily engaged in the wholesale and distribution of pharmaceutical products across mainland China and Hong Kong. The firm also offers hemodialysis treatment and associated consultancy services. Its pharmaceutical goods are supplied to a diverse client base within Fujian province, including hospitals, various healthcare institutions, pharmaceutical retail chains, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Established in 2004, the company is headquartered in Kowloon, Hong Kong.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is underpriced on P/FCF.